Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Year-over-year revenue growth rate
5Y CAGR
-16.8%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 21.31% |
| 2024 | 185.66% |
| 2023 | 54.14% |
| 2022 | -3.79% |
| 2021 | -65.52% |
| 2020 | 53.37% |
| 2019 | -19.57% |
| 2018 | 0.00% |
| 2017 | 0.00% |
| 2016 | 0.00% |